dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Peg Camara, Vicente |
dc.contributor.author | Rabanal, Rosa Maria |
dc.contributor.author | Zamora Adelantado, Esther |
dc.contributor.author | Molina, Elisa |
dc.contributor.author | Arribas López, Joaquin Vicente |
dc.contributor.author | Cortés Castan, Javier |
dc.contributor.author | Bernadó Morales, Cristina |
dc.contributor.author | Aran Garriga, Andrea |
dc.date.accessioned | 2022-05-30T12:59:02Z |
dc.date.available | 2022-05-30T12:59:02Z |
dc.date.issued | 2021-11 |
dc.identifier.citation | Aran A, Peg V, Rabanal RM, Bernadó C, Zamora E, Molina E, et al. Epstein–Barr Virus+ B Cells in Breast Cancer Immune Response: A Case Report. Front Immunol. 2021 Nov;12:761798. |
dc.identifier.issn | 1664-3224 |
dc.identifier.uri | https://hdl.handle.net/11351/7580 |
dc.description | Limfòcits B; Virus d'Epstein-Barr; Càncer de mama |
dc.description.sponsorship | This project was funded by Roche Farma, S.A. grant SP181123001 and the Spanish Ministry of Science, Innovation and Universities grant RTI2018-097414-B-I00. Partial financial support was received from the “El Paseíco de la Mama” 2015. This study received partial funding from Roche Farma, S.A. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication. |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Immunology;12 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer - Immunologia |
dc.subject | Cèl·lules T - Receptors |
dc.subject | Cèl·lules B - Immunologia |
dc.subject.mesh | Triple Negative Breast Neoplasms |
dc.subject.mesh | /immunology |
dc.subject.mesh | Receptors, Antigen, T-Cell |
dc.subject.mesh | B-Lymphocytes |
dc.title | Epstein–Barr Virus+ B Cells in Breast Cancer Immune Response: A Case Report |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fimmu.2021.761798 |
dc.subject.decs | neoplasias de mama triple negativos |
dc.subject.decs | /inmunología |
dc.subject.decs | receptores de antígenos de linfocitos T |
dc.subject.decs | linfocitos B |
dc.relation.publishversion | https://doi.org/10.3389/fimmu.2021.761798 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Aran A, Molina E] Unitat d’Immunologia, Departament de Biologia Cel•lular, Fisiologia i Immunologia, Institut de Biotecnologia i Biomedicina (IBB), Universitat Autònoma de Barcelona, Bellaterra, Spain. [Peg V] Grup de Recerca en Patologia Molecular Translacional, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Rabanal RM] Unitat de Patologia Murina i Comparada, Departament de Medicina i Cirurgia Animal, Facultat de Veterinària, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Bernadó C] Preclinical and Translational Research Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Zamora E] Breast Cancer Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Arribas J] Preclinical and Translational Research Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain. Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. [Cortés J] Breast Cancer Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. International Breast Cancer Center (BCC), Quironsalud Group, Barcelona, Spain |
dc.identifier.pmid | 34868006 |
dc.identifier.wos | 000726121400001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |